Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai Translational Mission
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The Cardiovascular Research Center (CVRC) at Icahn School of Medicine at Mount Sinai was established in 2007 and is focused on advancing our knowledge of cardiovascular diseases and translating these discoveries into effective therapies. The CVRC is currently housed in The Leon and Norma Hess Center for Science and Medicine, a state-of-the-art clinical and research facility in New York’s Upper East Side. The Center is part of the Mount Sinai Health System, comprised of the Icahn School of Medicine at Mount Sinai and 7 other hospital campuses throughout the New York Metropolitan Area.
Since its inception, the CVRC has grown to include ≈75 members composed of physicians, physician-scientists, postdoctoral fellows, research scientists, and technicians. Our team of lead investigators and researchers work across platforms to investigate cardiac and stem cell biology, tissue engineering, vector biology, cardiac physiology, electrophysiology, vascular diseases, metabolic disorders, imaging, and clinical trials. Close collaboration and shared vision among the investigators glean fundamental insights into cardiovascular physiology and pathobiology, which illuminate potential avenues for therapeutic treatment.
The Center currently has 2 full professors, 5 associate professors, 10 assistant professors, and 4 instructors in medicine/cardiology. In 2017, total National Institutes of Health funding increased to >14 million dollars. In addition to 15 R01s, 3 K awards, and an F30, the CVRC is home to 3 Transatlantic Leducq Foundation grants, 4 American Heart Association postdoctoral fellowships, 4 American Heart Association Scientist Development grants, an American Heart Association Strategically Focused Research Network, a Department of Defence Concept Award, and a National Institutes of Health S10 Shared Instrument grant. We have also recently acquired funding from 2 biotechnology companies. Figure shows the junior and senior investigators at the Cardiovascular Research Center.